cardiocore lab ltd

Live EstablishedMicroDeclining

cardiocore lab ltd Company Information

Share CARDIOCORE LAB LTD

Company Number

05732513

Shareholders

biotelemetry inc

Group Structure

View All

Industry

Other business support service activities n.e.c.

 

Registered Address

ascent 1 aerospace boulevard, farnborough, GU14 6XW

cardiocore lab ltd Estimated Valuation

£2.9k

Pomanda estimates the enterprise value of CARDIOCORE LAB LTD at £2.9k based on a Turnover of £2.9k and 0.99x industry multiple (adjusted for size and gross margin).

cardiocore lab ltd Estimated Valuation

£7m

Pomanda estimates the enterprise value of CARDIOCORE LAB LTD at £7m based on an EBITDA of £961.7k and a 7.25x industry multiple (adjusted for size and gross margin).

cardiocore lab ltd Estimated Valuation

£0

Pomanda estimates the enterprise value of CARDIOCORE LAB LTD at £0 based on Net Assets of £-23.9k and 2.13x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Cardiocore Lab Ltd Overview

Cardiocore Lab Ltd is a live company located in farnborough, GU14 6XW with a Companies House number of 05732513. It operates in the other business support service activities n.e.c. sector, SIC Code 82990. Founded in March 2006, it's largest shareholder is biotelemetry inc with a 100% stake. Cardiocore Lab Ltd is a established, micro sized company, Pomanda has estimated its turnover at £2.9k with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Cardiocore Lab Ltd Health Check

Pomanda's financial health check has awarded Cardiocore Lab Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

2 Strong

positive_score

1 Regular

positive_score

4 Weak

size

Size

annual sales of £2.9k, make it smaller than the average company (£4.8m)

£2.9k - Cardiocore Lab Ltd

£4.8m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -73%, show it is growing at a slower rate (6.6%)

-73% - Cardiocore Lab Ltd

6.6% - Industry AVG

production

Production

with a gross margin of 99.2%, this company has a lower cost of product (38.3%)

99.2% - Cardiocore Lab Ltd

38.3% - Industry AVG

profitability

Profitability

an operating margin of 33082.3% make it more profitable than the average company (5.7%)

33082.3% - Cardiocore Lab Ltd

5.7% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (27)

1 - Cardiocore Lab Ltd

27 - Industry AVG

paystructure

Pay Structure

on an average salary of £54k, the company has an equivalent pay structure (£54k)

£54k - Cardiocore Lab Ltd

£54k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £2.9k, this is less efficient (£171.4k)

£2.9k - Cardiocore Lab Ltd

£171.4k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Cardiocore Lab Ltd

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Cardiocore Lab Ltd

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Cardiocore Lab Ltd

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Cardiocore Lab Ltd

- - Industry AVG

debtlevel

Debt Level

There is insufficient data available for this Key Performance Indicator!

- - Cardiocore Lab Ltd

- - Industry AVG

CARDIOCORE LAB LTD financials

EXPORTms excel logo

Cardiocore Lab Ltd's latest turnover from December 2023 is £2.9 thousand and the company has net assets of -£23.9 thousand. According to their latest financial statements, Cardiocore Lab Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover2,9073,184146,685145,846151,480148,538143,043143,007117,382127,916104,33496,77496,187108,871246,300
Other Income Or Grants
Cost Of Sales2310,46491,82491,58794,45593,14889,22988,79160,79961,58051,48448,01049,28457,898244,186
Gross Profit2,884-7,28054,86154,25957,02555,39053,81454,21756,58366,33652,84948,76346,90350,9722,113
Admin Expenses-958,85736,67023,025170,58327,81382,65895,733140,353117,06699,94659,42465,73151,33153,74049,126
Operating Profit961,741-43,95031,836-116,32429,212-27,268-41,919-86,136-60,483-33,610-6,575-16,968-4,428-2,768-47,013
Interest Payable266
Interest Receivable9644220407713641
Pre-Tax Profit722,221-43,08031,666-116,27929,432-26,861-41,206-85,495-58,915-32,721-6,285-16,609-4,106-2,607-47,013
Tax-6,016-5,592
Profit After Tax722,221-43,08025,649-116,27923,840-26,861-41,206-85,495-58,915-32,721-6,285-16,609-4,106-2,607-47,013
Dividends Paid
Retained Profit722,221-43,08025,649-116,27923,840-26,861-41,206-85,495-58,915-32,721-6,285-16,609-4,106-2,607-47,013
Employee Costs53,95951,30948,76046,40645,97044,27141,97742,05254,16458,72248,43344,99144,13149,897197,046
Number Of Employees111111111111112
EBITDA*961,741-43,95031,836-116,32429,212-27,268-41,919-86,136-60,483-33,610-6,531-16,843-3,688-2,068-46,287

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets411619261,686
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets411629271,687
Stock & work in progress
Trade Debtors
Group Debtors
Misc Debtors6,9667,89214,04812,37112,77013,15711,42713,2316,8767,2396,5483,5354,7843,884
Cash48,34524,45852,34836,28122,26586,238199,117313,926313,24542,25673,62269,88958,9215,683
misc current assets
total current assets55,31232,35166,39748,65335,03699,396210,544327,158320,12149,49580,17173,42463,7059,568
total assets55,31232,35166,39748,65335,03699,396210,544327,158320,12149,49580,21273,58664,63211,255
Bank overdraft8778,517
Bank loan
Trade Creditors
Group/Directors Accounts763,820696,230765,989634,436649,092686,682758,213783,724722,154370,298375,019346,792342,565291,580
other short term finances
hp & lease commitments
other current liabilities23,06537,65526,82025,19822,87818,34318,25216,72322,34420,65516,43713,79812,33811,55717,055
total current liabilities23,943801,475731,568791,188657,315667,435704,934774,936806,068742,809386,736388,818359,131354,123308,635
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities23,943801,475731,568791,188657,315667,435704,934774,936806,068742,809386,736388,818359,131354,123308,635
net assets-23,942-746,163-699,217-724,791-608,662-632,399-605,538-564,392-478,911-422,689-337,241-308,606-285,545-289,491-297,380
total shareholders funds-23,942-746,163-699,217-724,791-608,662-632,399-605,538-564,392-478,911-422,689-337,241-308,606-285,545-289,491-297,380
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit961,741-43,95031,836-116,32429,212-27,268-41,919-86,136-60,483-33,610-6,575-16,968-4,428-2,768-47,013
Depreciation44125739700725
Amortisation
Tax-6,016-5,592
Stock
Debtors-6,966-926-6,1561,677-399-3871,730-1,8046,355-3636913,013-1,2499003,884
Creditors
Accruals and Deferred Income-14,59010,8351,6222,3204,535911,529-5,6211,6894,2182,6391,460781-5,49817,055
Deferred Taxes & Provisions
Cash flow from operations954,117-32,18933,598-115,68128,554-26,790-42,120-89,953-65,149-29,029-4,583-18,396-1,659-8,466-33,117
Investing Activities
capital expenditure-3-52660-2,411
Change in Investments
cash flow from investments-3-52660-2,411
Financing Activities
Bank loans
Group/Directors Accounts-763,82067,590-69,759131,553-14,656-37,590-71,531-25,51161,569351,856-4,72128,2274,22750,985291,580
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue-3,866-75150-10260142,693-52,727-22,350-6,4528,05210,496-250,367
interest-17044220407713641
cash flow from financing-763,82063,724-70,004131,747-14,538-37,183-70,758-24,85664,262299,129-27,07121,77512,27961,48141,213
cash and cash equivalents
cash-48,34523,887-27,89016,06714,017-63,973-112,879-114,809682270,989-31,3663,73410,96753,2385,683
overdraft877-8,5178,517
change in cash-49,22232,404-36,40716,06714,017-63,973-112,879-114,809682270,989-31,3663,73410,96753,2385,683

cardiocore lab ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for cardiocore lab ltd. Get real-time insights into cardiocore lab ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Cardiocore Lab Ltd Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for cardiocore lab ltd by selecting its closest rivals, whether from the ADMINISTRATIVE AND SUPPORT SERVICE ACTIVITIES sector, other micro companies, companies in GU14 area or any other competitors across 12 key performance metrics.

cardiocore lab ltd Ownership

CARDIOCORE LAB LTD group structure

Cardiocore Lab Ltd has no subsidiary companies.

Ultimate parent company

BIOTELEMETRY INC

#0168042

1 parent

CARDIOCORE LAB LTD

05732513

CARDIOCORE LAB LTD Shareholders

biotelemetry inc 100%

cardiocore lab ltd directors

Cardiocore Lab Ltd currently has 2 directors. The longest serving directors include Mrs Louise Best (Jun 2021) and Mr Mark Leftwich (Apr 2022).

officercountryagestartendrole
Mrs Louise BestEngland44 years Jun 2021- Director
Mr Mark LeftwichEngland46 years Apr 2022- Director

P&L

December 2023

turnover

2.9k

-9%

operating profit

961.7k

0%

gross margin

99.3%

-143.39%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

-23.9k

-0.97%

total assets

0

-1%

cash

0

-1%

net assets

Total assets minus all liabilities

cardiocore lab ltd company details

company number

05732513

Type

Private limited with Share Capital

industry

82990 - Other business support service activities n.e.c.

incorporation date

March 2006

age

19

incorporated

UK

ultimate parent company

BIOTELEMETRY INC

accounts

Small Company

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

MHA

address

ascent 1 aerospace boulevard, farnborough, GU14 6XW

Bank

-

Legal Advisor

-

cardiocore lab ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to cardiocore lab ltd.

cardiocore lab ltd Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for CARDIOCORE LAB LTD. This can take several minutes, an email will notify you when this has completed.

cardiocore lab ltd Companies House Filings - See Documents

datedescriptionview/download